Tesamorelin

Tesamorelin is a synthetic GHRH analogue (the hormone that triggers the release of somatotropin), stabilized against enzymatic degradation unlike native GHRH(1-44). In research it has been studied primarily in connection with visceral fat and the growth-hormone axis.

A naming caveat: under the same international name there is a separate, regulator-approved drug product for a specific clinical indication, manufactured under its own brand to pharmaceutical standard. Longeva's material is a different, unapproved research compound not regulated as a medicine, and the two should not be equated.